title: [Hungarian national plan and strategy for rare diseases].
abstract: The rarity of low prevalence diseases and the lack of information, research, diagnosis, treatment and expert availability may mean that the people affected do not benefit from the health resources and services they need. Rare diseases are considered to have little impact on society as a whole, yet they pose serious difficulties for sufferers and their families. By the end of the last century, two robust achievements in science and technology, i.e. the biotechnological and informatics revolutions, have created a real base for global approach to rare diseases by coordinating the capacities for health care, biomedical research and drug development and pooling the very limited resources available both nationally and transnationally. The European Commission has taken a number of actions which help patients and professionals to share expertise and information across borders with the objective of reducing the number of people suffering from these types of diseases. These actions together form the legal basis of the European Union policy on rare diseases. Orphan or rare diseases are now one of the priorities in the public health programmes in European Union. In 2009, the document "European Union Council Recommendation on an action in the field of rare diseases" was released with the main goal to provide national health authorities with supporting tools for the development and implementation of national plans and strategies for rare diseases by the end of 2013. This recommendation adopted by European Union Member States, allows common policy guidelines to be shared everywhere in Europe. By September 2013 the Hungarian National Plan for Rare Diseases, a health policy strategy until 2020 was finalized. The present report gives a short view on the document.
authors.affiliation: Pécsi Tudományegyetem, Általános Orvostudományi Kar Orvosi Genetikai Intézet Pécs Szigeti út 12. 7623.
authors.forename: György
authors.initials: G
authors.lastname: Kosztolányi
mesh_terms: D035843:Biomedical Research; D003255:Consumer Organizations; D004502:Education, Medical, Continuing; D005062:European Union; D006291:Health Policy / Q000331:legislation & jurisprudence / Q000639:trends; D006801:Humans; D006814:Hungary; D009313:National Health Programs / Q000331:legislation & jurisprudence / Q000639:trends; D010344:Patient Advocacy; D011634:Public Health; D035583:Rare Diseases / Q000175:diagnosis / Q000188:drug therapy
keywords: National Plan and Strategy for Rare Diseases; Ritka Betegségek Nemzeti Terve; rare diseases; ritka betegségek